Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMCI vs HCAC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HCAC Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

HCAC Overall Winner 6-Pillar Tally: AMCI 0 – 0 HCAC (6 Tie) Matrix Metrics: AMCI 0 – 3 HCAC

As of Nov 16, 2026, HCAC (HCAC) is the stronger overall head-to-head candidate over AMCI (AMCI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AMCI carries a Unified Composite Score of 49.6/100 (HOLD) at $0.88 (N/M Forward P/E, N/A operating margin), whereas HCAC carries 57.2/100 (HOLD) at $10.26 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: AMCI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.0); meanwhile HCAC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 80.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMCI vs HCAC
AMCI US Equity
AMCI
Institutional Equity
$0.88
-5.42% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.93β · 164% Vol
Unified Composite Score
49.6 / 100 HOLD
Tech 50.0 Fund 54.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.1%), weak momentum, RSI 24
RSI-14: 24.0 · SMA20: $1.65 · SMA50: $2.48
HCAC US Equity Head-to-Head Winner
HCAC
Institutional Equity
$10.26
+0.2% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 2% Vol
Unified Composite Score
57.2 / 100 HOLD
Tech 58.0 Fund 50.0 Flow 50.0 Mom 36.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 81
RSI-14: 80.8 · SMA20: $10.16 · SMA50: $10.13

6-Pillar Scorecard Institutional Category Breakdown (AMCI 0 – 0 HCAC)

Columns: Metric · AMCI · HCAC
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMCI (0) vs HCAC (3)
Institutional Metric AMCI HCAC Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
0% ($1–$15) 100% ($10–$10) Stronger Trend HCAC
Beta / 30D Volatility
Risk Regime
2.93β · 164% Vol 0.02β · 2% Vol Lower Realized Risk HCAC
Unified Institutional Score
Composite Signal
49.6 / 100 (HOLD) 57.2 / 100 (HOLD) Higher Composite HCAC
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HCAC +73.5 pp
AMCI: -72.42% · HCAC: +1.08%
3M Horizon HCAC +81.28 pp
AMCI: -79.39% · HCAC: +1.89%
6M Horizon HCAC +90.05 pp
AMCI: -86.93% · HCAC: +3.12%
1Y Horizon HCAC +88.94 pp
AMCI: -85.72% · HCAC: +3.22%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMCI vs HCAC. Trailing 12-month operating profitability (AMCI N/A vs HCAC N/A) and valuation multiples (AMCI N/M vs HCAC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AMCI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HCAC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMCI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AMCI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HCAC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HCAC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMCI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HCAC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AMCI vs HCAC Key Questions & Quantitative Answers

As of Nov 16, 2026, HCAC (HCAC) is the stronger overall head-to-head candidate over AMCI (AMCI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AMCI carries a Unified Composite Score of 49.6/100 (HOLD) at $0.88 (N/M Forward P/E, N/A operating margin), whereas HCAC carries 57.2/100 (HOLD) at $10.26 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: AMCI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.0); meanwhile HCAC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 80.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMCI and HCAC split Growth & Scale metrics: AMCI posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HCAC at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AMCI generates N/A in USD-normalized revenue versus N/A for HCAC. In operating R&D and SG&A reinvestment, AMCI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HCAC.

AMCI and HCAC trade at balanced relative valuation multiples. AMCI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HCAC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMCI (N/A ROE) versus HCAC (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, AMCI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.93β · 164% Vol realized risk). By comparison, HCAC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.